CN Patent

CN106852118A — 阿瑞吡坦乳剂制剂

Assigned to Heron Therapeutics LLC · Expires 2017-06-13 · 9y expired

What this patent protects

本发明公开了新型阿瑞吡坦药物制剂，其适合包括静脉施用在内的肠胃外施用。也公开了包含阿瑞吡坦和地塞米松磷酸钠的制剂。药物制剂为稳定的水包油乳剂，用于非口服地治疗呕吐，并特别可用于治疗经受高致吐癌症化疗的对象。

USPTO Abstract

本发明公开了新型阿瑞吡坦药物制剂，其适合包括静脉施用在内的肠胃外施用。也公开了包含阿瑞吡坦和地塞米松磷酸钠的制剂。药物制剂为稳定的水包油乳剂，用于非口服地治疗呕吐，并特别可用于治疗经受高致吐癌症化疗的对象。

Drugs covered by this patent

Patent Metadata

Patent number
CN106852118A
Jurisdiction
CN
Classification
—
Expires
2017-06-13
Drug substance claim
No
Drug product claim
No
Assignee
Heron Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.